Clinical Genomics Nabs Medicare Coverage for Colorectal Cancer Test as Novitas Revises LCD

The MAC Novitas recently revised the LCD, adding several biomarkers for a variety of leukemias and replacing original coverage of the ThyGenX panel with the ThyGeNEXT panel upon request. Additional leukemia biomarkers were requested for acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, hairy cell leukemia, myeloproliferative diseases, prolymphocytic leukemia, and T cell large granular lymphocytic leukemia.

The revised LCD goes into effect Dec. 13.

Source: https://www.genomeweb.com/reimbursement-news/clinical-genomics-nabs-medicare-coverage-colorectal-cancer-test-novitas-revises